Conquering Diseases

A Study Of An Investigational Vaccine For Respiratory Syncytial Virus (R S V) In Adults


Seeking men and women 60 years of age for the study of an investigational vaccine against Respiratory Syncytial Virus


Participants in this trial will be randomly assigned to receive either the investigational vaccine or a placebo (looks like the vaccine, but doesn't contain medication). There will be about 4 clinic visits over 3 years. Visits may include exams, questionnaires, blood draws, nasal swabs, and injections.

What we're hoping for

To determine if the study vaccine, RSVpreF, is safe and effective in preventing RSV infections compared to a placebo.

Additional Information Identifier: NCT05035212

 Principal Investigator

Mary Dawn  Co, MD

University of Massachusetts Medical School

 Study Contact

Melissa  Adams



UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655